PHARMOVO LTD
Company number 12542632 · Monitor this company
Executive summary
PHARMOVO LTD demonstrates a high-risk profile due to stagnant minimal net assets, limited operational scale, and a sole director with potentially limited management experience. While regulatory filings are up to date and liabilities are absent, the absence of growth or trading activity raises concerns about the company’s sustainability. Further due diligence on revenue generation, business viability, and management capability is recommended before considering investment.
Shareholders' funds
£137
Balance sheet as at 2025-04-30
What it does
62012
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-04-01
- Employees
- 4 (2025 accounts · was 0 in 2024)
- Registered office
- Suite 4 New Humberstone House, 40 Thurmaston Lane, Leicester, England, LE5 0TE
- Postcode
- LE5 0TE
- Capital
- 1,000 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-04-30
- Next due by
- 2027-01-31
- Financial year end
- 30 April
Confirmation statement
- Last statement dated
- 2026-08-03
- Next due by
- 2027-08-17
Nature of business (SIC)
- 62012 Business and domestic software development
Officers 1 current
Contact details
- Website
- pharmovo.co.uk
Predicting Pharmaceutical Demand & Shortages. Pharmovo AI combines artificial intelligence with pharmaceutical expertise to prevent drug shortages and optimize supply chains for healthcare systems, NHS boards, and pharma companies.
Previous company names
| Name | Date changed |
|---|---|
| LIL PHARMA LTD | 2020-06-22 |
| PHARMAVO LTD | 2020-05-07 |
| PHARMAXO LTD | 2020-04-17 |
At this address
Among the biggest employers
of 359 similar companies in LE, with 4 staff.
Competitors Leicester
This company ranks 321 among business and domestic software development in Leicester.
The class of 2020
37%
of the 9,511 companies in this sector incorporated in 2020 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.